Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
- PMID: 33406336
- PMCID: PMC10588929
- DOI: 10.1056/NEJMc2033206
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis
Comment in
-
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis. Reply.N Engl J Med. 2021 Jan 7;384(1):83-84. doi: 10.1056/NEJMc2033206. N Engl J Med. 2021. PMID: 33406337 No abstract available.
Comment on
-
Trial of Upadacitinib or Abatacept in Rheumatoid Arthritis.N Engl J Med. 2020 Oct 15;383(16):1511-1521. doi: 10.1056/NEJMoa2008250. N Engl J Med. 2020. PMID: 33053283 Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical